Technology and innovation is the backbone of Embio’s success, which allows us to achieve a leadership position as a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Speciality chemicals catering to a range of global customers in the pharmaceutical, nutraceutical, food, cosmetic, crop & plant protection segments. With 30+ years of experience in handling bacterial, fungal & Category 1 GMO bio-transformation, Embio has demonstrated an impeccable track record in creating sustainable, environmental friendly and disruptive technologies. With licenses to manufacture Schedule-1 & Schedule-2 substances, Embio is a leading global player in the domain of controlled substances, advanced intermediates & chiral molecules. Embio’s State of the Art manufacturing facility is approved by US-FDA, PMDA, KFDA, COFEPRIS & WHO-GMP. Our products & services cater to the stringent requirements of a large customer base in more than 70 countries, with a major share from regulated markets that includes originator and large multi-national companies.
Read MoreEmployees
Operating Years
Countries
Regulatory approvals